0001562180-23-007332.txt : 20231017
0001562180-23-007332.hdr.sgml : 20231017
20231017181156
ACCESSION NUMBER: 0001562180-23-007332
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231016
FILED AS OF DATE: 20231017
DATE AS OF CHANGE: 20231017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Linetsky David
CENTRAL INDEX KEY: 0001776729
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38977
FILM NUMBER: 231330539
MAIL ADDRESS:
STREET 1: C/O PHREESIA, INC.
STREET 2: 432 PARK AVENUE S., 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phreesia, Inc.
CENTRAL INDEX KEY: 0001412408
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0131
BUSINESS ADDRESS:
STREET 1: 1521 CONCORD PIKE
STREET 2: SUITE 301 PMB 221
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 888-654-7473
MAIL ADDRESS:
STREET 1: 1521 CONCORD PIKE
STREET 2: SUITE 301 PMB 221
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: Phreesia Inc
DATE OF NAME CHANGE: 20070914
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2023-10-16
false
0001412408
Phreesia, Inc.
PHR
0001776729
Linetsky David
C/O PHREESIA, INC.
1521 CONCORD PIKE, SUITE 301 PMB 221
WILMINGTON
DE
19803
false
true
false
false
SVP, Life Sciences
false
Common Stock
2023-10-16
4
S
false
2078.00
16.609
D
215036.00
D
Common Stock
7832.00
I
By Spouse
These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.46 to $16.85 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Allison Hoffman by Power of Attorney for David Linetsky
2023-10-17